XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.55%)
As of: Sep 30, 2026 · 9:54 AM EDT

XORTX Therapeutics (XRTX) EV to EBIT (2022)

Updated

XORTX Therapeutics' EV to EBIT was 6.36 in the year ended Dec 31, 2024.

Analysis

XORTX Therapeutics (XRTX) EV to EBIT (2022) Analysis & Trends

  • The figure for the year ended Dec 31, 2024 marks the highest annual EV to EBIT since the year ended Dec 31, 2021.
  • Per Business Quant data, EV to EBIT in earlier years was 28.94 in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 XORTX Therapeutics 1.62 Mn -1.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 58.48
API Access

XORTX Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=XRTX&period=max&api_key=YOUR_API_KEY